The role of treatment duration in chemotherapy regimens for the treatment of malignant diseases

被引:0
|
作者
Trümper, L [1 ]
Pfreundschuh, M [1 ]
机构
[1] Univ Saarlandes Kliniken, D-66421 Homburg, Germany
关键词
chemotherapy; treatment duration; dose intensity; remission rate;
D O I
10.1007/PL00002312
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The treatment of malignant tumors consists in the optimal combination of the 4 modalities surgery, radiotherapy, chemotherapy, and immunotherapy. An important goal of clinical research is the development of the optimal application of each of these modalities. Method: This review of the literature focuses on the importance of the total treatment duration and dose intensity in the development of chemotherapy regimens. Three important malignant diseases will be examined as to thr: optimal application of systemic chemotherapy. Result and Conclusion: Tumor models with the resulting hypotheses and well-designed clinical trials will Lead to progress in the treatment of malignant tumors.
引用
收藏
页码:466 / 471
页数:10
相关论文
共 50 条
  • [21] TREATMENT OF MALIGNANT DISEASES WITH CYTOSTATICS
    MOE, PJ
    ACTA PAEDIATRICA SCANDINAVICA, 1970, 59 (02): : 228 - +
  • [22] The treatment of malignant diseases in the mouth
    Grier, GW
    AMERICAN JOURNAL OF ROENTGENOLOGY AND RADIUM THERAPY, 1924, 12 : 347 - 352
  • [23] The treatment of malignant diseases of the skin
    Adamson, HG
    BRITISH MEDICAL JOURNAL, 1915, 1915 : 618 - 619
  • [24] The treatment of malignant diseases of the skin
    Kempstep, C
    BRITISH MEDICAL JOURNAL, 1915, 1915 : 660 - 660
  • [25] The treatment of malignant diseases of the skin
    Sequeira, JH
    BRITISH MEDICAL JOURNAL, 1915, 1915 : 577 - 577
  • [26] Chemotherapy regimens and treatment protocols for laryngeal cancer
    Haigentz, Missak, Jr.
    Silver, Carl E.
    Hartl, Dana M.
    Takes, Robert P.
    Rodrigo, Juan P.
    Robbins, K. Thomas
    Rinaldo, Alessandra
    Ferlito, Alfio
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (08) : 1305 - 1316
  • [27] ADHERENCE TO TREATMENT REGIMENS IN PATIENTS WITH CARDIOVASCULAR DISEASES
    Dimunova, Lucia
    Michalkova, Jana
    Zamboriova, Maria
    Buckova, Jana
    Nagyova, Iveta
    HEALTH PROBLEMS OF CIVILIZATION, 2021, 15 (04) : 270 - 274
  • [28] Systemic chemotherapy in the treatment of malignant melanoma
    Lens, MB
    Eisen, TG
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (12) : 2205 - 2211
  • [29] PREOPERATIVE CHEMOTHERAPY IN THE TREATMENT OF MALIGNANT GLIOMA
    FEWER, D
    HILL, NC
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1979, 6 (03) : 377 - 377
  • [30] TREATMENT OF MALIGNANT PHEOCHROMOCYTOMA WITH COMBINATION CHEMOTHERAPY
    KEISER, HR
    GOLDSTEIN, DS
    WADE, JL
    DOUGLAS, FL
    AVERBUCH, SD
    HYPERTENSION, 1985, 7 (03) : I18 - I24